Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Discovery Platform
Sponsor : Serum Institute of India
Deal Size : Undisclosed
Deal Type : Collaboration
Primrose, Serum Institute Collaborate on Novel Multi-Antigen Vaccine Development
Details : The companies will contribute towards the design of the vaccine with Primrose fully responsible for developing strains using its Pfenex Technology and SIIPL responsible for further commercialization.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Undisclosed
January 10, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Discovery Platform
Sponsor : Serum Institute of India
Deal Size : Undisclosed
Deal Type : Collaboration